Showing results (2141-2150 of 2,308) with videos related to
Sort By:
Pageof 231
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2011
Troponin I and C-reactive protein are commonly detected in patients with breast cancer treated with dose-dense chemotherapy incorporating trastuzumab and lapatinibPatrick G Morris, Carol Chen, Richard Steingart, et al.Metabolism: Clinical and Experimental|July 10, 2026
The endogenous ghrelin antagonist, LEAP2, accelerates puberty onset in conditions of early obesityCarmen Torres-Granados, Paul G Morris, Miguel Ruiz-Cruz, et al.Journal of Structural Biology|December 10, 2017
Correlative imaging reveals physiochemical heterogeneity of microcalcifications in human breast carcinomasJennie A M R Kunitake, Siyoung Choi, Kayla X Nguyen, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 11, 2009
Dose-dense adjuvant Doxorubicin and cyclophosphamide is not associated with frequent short-term changes in left ventricular ejection fractionPatrick G Morris, Maura Dickler, Heather L McArthur, et al.Disease Models & Mechanisms|August 17, 2022
A clinically relevant model of acute respiratory distress syndrome in human-size swineSarah R Kaslow, Jonathan A Reimer, Meghan R Pinezich, et al.Lung Cancer (Amsterdam, Netherlands)|May 8, 2022
Exhaled Breath Condensate (EBC) analysis of circulating tumour DNA (ctDNA) using a lung cancer specific UltraSEEK oncogene panelDaniel J Ryan, Sinead Toomey, Robert Smyth, et al.The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|August 26, 1999
Spinal-flexibility-plus-aerobic versus aerobic-only training: effect of a randomized clinical trial on function in at-risk older adultsM C Morey, M Schenkman, S A Studenski, et al.Cancer Immunology Research|December 8, 2025
A universal boosting strategy for adoptive T cell therapy using a paired vaccine/chimeric antigen receptorRebecca Burchett, Claire G Morris, Mira Ishak, et al.Neuroimage. Clinical|July 31, 2022
Determining the OPTIMAL DTI analysis method for application in cerebral small vessel diseaseMarco Egle, Saima Hilal, Anil M Tuladhar, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 9, 2013
Rituximab, methotrexate, procarbazine, and vincristine followed by consolidation reduced-dose whole-brain radiotherapy and cytarabine in newly diagnosed primary CNS lymphoma: final results and long-term outcomePatrick G Morris, Denise D Correa, Joachim Yahalom, et al.Pageof 231